Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3050-3058

  Degnan, B A ^a   Palmer, J M ^a   Robson, T ^a   Jones, C E D ^a   Fischer, M ^a   Glanville, M ^a   Mellor, G D ^a   Diamond, A G ^a   Kehoe, M A ^a   Goodacre, J A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DEIMINASE; BACTERIAL PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MYCOPLASMA HOMINIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; SEQUENCE HOMOLOGY; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE;

EID: 0031814271     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3050-3058.1998     Document Type: Article

References (52)

1. Baird, R. W., M. S. Bronze, W. Kraus, H. R. Hill, L. G. Veasey, and J. B. Dale. 1991. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J. Immunol. 146:3132-3137.
2. Bairoch, A., and R. Apweiler. 1996. The SWISS-PROT protein sequence data bank and its new supplement TrEMBL. Nucleic Acids Res. 24:21-25.
3. Bernheimer, A. W. 1972. Hemolysins of streptococci: characterization and effects on biological membranes, p. 19-31. In L. W. Wannamaker and J. M. Matsen (ed.), Streptococci and streptococcal diseases. Academic Press Inc., New York, N.Y.
4. Bisno, A. L. 1991. Group A streptococcal infections and rheumatic fever. N. Engl. J. Med. 325:783-793.
5. Bisno, A. L. 1993. Acute rheumatic fever: a present-day perspective. Medicine 72:278-283.
6. Bonavida, B., and A. Jewett. 1989. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-γ. Cell. Immunol. 123: 373-383.
7. Braun, M. A., D. Gerlach, U. F. Hartwig, J.-H. Ozegowski, F. Romanagne, S. Carrel, W. Kohler, and B. Fleischer. 1993. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J. Immunol. 150:2457-2466.
8. Casiano-Colon, A., and R. E. Marquis. 1988. Role of arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl. Environ. Microbiol. 54:1318-1324.
9. Charlton, F. G., R. J. Smith, G. Pyle, M. A. Kehoe, and J. H. Robinson. 1997. Hierarchy of SPEA presentation to T cells by murine MHC haplotypes. Eur. J. Immunogenet. 24:423-430.
10. Cunin, R., N. Glansdorff, A. Pierard, and V. Stalon. 1986. Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 50:314-352.
11. Curran, T. M., J. Lieou, and R. E. Marquis. 1995. Arginine deiminase system and acid adaptation of oral streptococci. Appl. Environ. Microbiol. 61:4494-4496.
12. Degnan, B. A., M. A. Kehoe, and J. A. Goodacre. 1997. Analysis of human T cell responses to group A streptococci using fractionated Streptococcus pyogenes proteins. FEMS Immunol. Med. Microbiol. 17:161-170.
13. Degnan, B. A., J. Taylor, C. Hawkes, U. O'Shea, J. Smith, J. H. Robinson, M. A. Kehoe, A. Boylston, and J. A. Goodacre. 1997. Streptococcus pyogenes type 5 M protein is an antigen, not a superantigen, for human T cells. Hum. Immunol. 53:206-215.
14. Efron, D. T., S. J. Kirk, M. C. Regan, H. L. Wasserkrug, and A. Barbul. 1991. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery 110:327-334.
15. Fleischer, B., K.-H. Schmidt, D. Gerlach, and W. Kohler. 1992. Separation of T-cell stimulating activity from streptococcal M protein. Infect. Immun. 60:1767-1770.
16. Ginsburg, I. 1972. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J. Infect. Dis. 126:294-340.
17. Gravekamp, C., R. Vreugdenhil, and R. L. H. Bolhuis. 1988. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level. FEMS Microbiol. Immunol. 47:31-40.
18. Haase, A., A. Melder, D. Kemp, and J. Mathews. 1994. Streptokinase alleles and disease association in group A streptococci. FEMS Immunol. Med. Microbiol. 10:75-80.
19. Hochstrasser, D. F., A. Patchornick, and C. R. Merril. 1989. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal. Biochem. 173:412-423.
20. Hu, Z.-L., E. Kubota, H. Imamura, M. Katano, and T. Katsuki. 1994. Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL2. Microbiol. Immunol. 38:183-190.
21. Itoh, T., H. Satoh, N. Isono, H. Rikiishi, and K. Kumagai. 1992. Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein. Infect. Immun. 60:3128-3135.
22. Iwasaki, M., H. Igarashi, Y. Hinuma, and T. Yutsudo. 1993. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett. 331:187-192.
23. Kanaoka, M., C. Kawanaka, T. Negoro, Y. Fukita, K. Taya, and H. Agui. 1987. Cloning and expression of the antitumour glycoprotein gene of Streptococcus pyogenes Su in Escherichia coli. Agric. Biol. Chem. 51:2641-2648.
24. Kanaoka, M., T. Negoro, C. Kawanaka, H. Agui, and S. Nabeshima. 1991. Streptococcal antitumour protein: expression in Escherichia coli cells and properties of the recombinant protein. Agric. Biol. Chem. 55:743-750.
25. Komada, Y., X.-L. Zhang, Y.-W. Zhou, M. Ido, and E. Azuma. 1997. Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase. Int. J. Hematol. 65:129-141.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Marciel, A. M., V. Kapur, and J. M. Musser. 1997. Molecular population genetic analysis of a Streptococcus pyogenes bacteriophage-encoded hyaluronidase gene: recombination contributes to allelic variation. Microb. Pathos. 22:209-217.
28. McMillian, R. A., T. A. Bloomster, A. M. Saeed, K. L. Henderson, N. E. Zinn, R. Abernathy, D. W. Watson, and R. N. Greenberg. 1987. Characterization of a fourth streptococcal pyrogenic exotoxin (SPED). FEMS Microbiol. Lett. 44:317-322.
29. Michie, C., A. Scott, J. Cheesbrough, P. Beverley, and G. Pasvol. 1994. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effects on T lymphocyte subsets in vivo. Clin. Exp. Immunol. 98:140-144.
30. Misawa, S., M. Aoshima, H. Takaku, M. Matsumoto, and H. Hayashi. 1994. High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J. Biotechnol. 36:145-155.
31. Miyazaki, K., H. Takaku, M. Umeda, T. Fujita, W. Huang, T. Kimura, J. Yamashita, and T. Horio. 1990. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res. 50:4522-4527.
32. Mollick, J. A., G. G. Miller, J. M. Musser, R. G. Cook, D. Grossman, and R. R. Rich. 1993. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92:710-719.
33. Norrby-Teglund, A., D. Newton, M. Kotb, S. E. Holm, and M. Norgren. 1994. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect. Immun. 62:5227-5233.
34. Oginsky, E. L. 1957. Isolation and determination of arginine and citrulline. Methods Enzymol. 3:639-643.
35. Ogita, S., T. Tsuto, K. Nakamura, E. Deguchi, K. Tokiwa, and N. Iwai. 1996. OK-432 therapy for lymphangioma in children: why and how does it work? J. Pediatr. Surg. 31:477-480.
36. Ozegowski, J. H., H. Knoll, D. Gerlach, and W. Kohler. 1984. Investigation of erythrogenic toxin C produced by Streptococcus pyogenes. Zentbl. Bakteriol. Mikrobiol. Hyg. Ser. A 257:38-50.
37. Rammelkamp, C. H., and R. S. Weaver. 1953. Acute glomerulonephritis. The significance of the variation in the incidence of the disease. J. Clin. Invest. 320:345-358.
38. Reda, K. B., V. Kapur, J. A. Mollick, J. G. Lamphear, J. M. Musser, and R. R. Rich. 1994. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect. Immun. 62:1867-1874.
39. Robinson, J. H., and M. A. Kehoe. 1992. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol. Today 13:362-367.
40. Sato, T., M. Fujii, H. Satoh, T. Itoh, H. Rikiishi, and K. Kumagai. 1992. Polyclonal activalion of human lymphocytes and induction of cytotoxic lymphocytes by streptococcal preparations. Biotherapy 4:53-63.
41. Schimke, R. T., C. M. Berlin, E. W. Sweeney, and W. R. Carroll. 1966. The Generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis O7. J. Biol. Chem. 241:2228-2236.
42. Schmidt, K. H., D. Gerlach, L. Wollweber, W. Reichardt, K. Mann, J. H. Ozegowski, and B. Fleischer. 1995. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF. Infect. Immun. 63:4569-4575.
43. Shibatani, T., T. Kakimoto, and I. Chibata. 1975. Crystallization and properties of L-arginine deiminase of Pseudomonas putida. J. Biol. Chem. 250: 4580-4583.
44. Stollerman, G. H. 1991. Rheumatogenic streptococci and autoimmunity. Clin. Immunol. Immunopathol. 61:131-142.
45. Tewodros, W., M. Norgren, and G. Kronvall. 1995. Streptokinase activity among group A streptococci in relation to streptokinase genotype, plasminogen binding, and diseases manifestations. Microb. Pathog. 18:53-65.
46. Tytell, A. A., and R. E. Neuman. 1960. Growth response of stable cell cultures to L-ornithine, L-citrulline, and L-arginine. Exp. Cell Res. 20:84-91.
47. Uchida, A., and M. Micksche. 1983. Intrapleural administration of OK-432 in cancer patients: activation of NK cells and reduction of suppressor cells. Int. J. Cancer 31:1-5.
48. Weickmann, J. L., and D. E. Fahrney. 1977. Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. J. Biol. Chem. 252:2615-2620.
49. Yamamoto, A., M. Nagamuta, H. Usami, Y. Sugawara, N. Watanabe, Y. Niitsu, and I. Urushizaki. 1985. Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation. Immunol. Lett. 11:83-88.
50. Yoshida, J., S. Takamura, and S. Suzuki. 1994. Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes. Anticancer Res. 14:1833-1838.
51. Yoshida, J., S. Takamura, S. Suzuki, and M. Nishio. 1996. Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein. Br. J. Cancer 73:917-923.
52. Yutsudo, T., H. Murai, J. Gonzalez, T. Takao, Y. Shimonishi, Y. Takeda, H. Igarashi, and Y. Hinuma. 1992. A new type of mitogenic factor produced by Streptococcus pyogenes. FEBS Lett. 1:30-34.